Valproate induced parkinsonism

Brain and Nerve

Volumn 50, Issue 1, 1998, Pages 81-84

  Park Matsumoto, Y C ^a   Tazawa, Toshiaki ^a  

^a Akiba Memorial Hospitai ^*  (Japan)

Author keywords

Epilepsy; Parkinsonism; Valproate

Indexed keywords

VALPROIC ACID;

AGED; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; EPILEPSY; FEMALE; HUMAN; MALE; PARKINSONISM;

AGED; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MALE; PARKINSON DISEASE, SECONDARY; VALPROIC ACID;

EID: 0031905162     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Alvarez-Gomez MJ, Vaamonde J, Narbona J, Barao M, Barona P, Brannan T, Gudin M, Ibanez R : Parkinsonian syndrome in childhood after sodium valproate administration. Clin Neuropharmacol 16 : 451-455, 1993
2. Armon C, Shin C, Miller P, Carwile S, Brown E, Edinger JD, Paul RG : Reversible parkinsonism and cognitive impairment with chronic valproate use, Neurology 47 : 026-635, 1996
3. Coulter DL, Allen RJ : Secondary hyperammonemia : A possible mechanism for valproate encephalopathy. Lancet 1 : 1310-1311, 1980
4. Gerber N, Dichinson RG, Harland RC, Lynn RK, Houghton D, Antonias JI, Sckimshock JC : Reyelike syndrome associated with valproic acid therapy. J Pediatr 95 : 142-144, 1979
5. Hyman NM, Dennis PD, Keith GA, Sinclair B : Tremor due to sodium valproate. Neurology 29 : 1177-1180, 1979
6. Lautin A, Stanley M, Negrotti A, Mancia D : Extrapyramidal syndrome with sodium valproate. British Medical Journal 27 : 1035-1036, 1979
7. Mizuno Y, Ohta S, Tanaka M : Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163 : 1450-1455, 1989
8. Nicklas WJ, Vyas Z, Heikkila RE : Inhibition of NADH-linked oxidation in brain mitochondria by 1-rnethyl-4-phenylpyridine, a metabolite of the neurotoxic 1 - methyl - 4 - phenyl - 1,2,3,6 - tetrahy-dropyridine. Life Sci 36 : 2503-2508, 1985
9. Park-Matsumoto YC, Tazawa T : Valproate induced lupus- like syndrome J Neurol Sci 143 : 185-186, 1996
10. Power C, Blume WT, Young GB : Reversible parkinsonism associated with valproate therapy Neurology 40 (Suppl 1) : 139, 1990
11. Sasso E, Delsoldato S, Negrotti A. Mancia D : Reversible valproate-induced extrapyramidal disorders Epilepsia 35 : 391-393, 1994
12. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD : Mitochondrial Complex I deficiency in Parkinson's disease. J Neurochem 54 : 823-827, 1990
13. Van Der Zwan AJR : Transient parkinson syndrome and tremor caused by the use of sodium valproate. Ned Tijdschr Geneeskd 133 : 1230-1232, 1989
14. Van Kammen DP : Gamma-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 134 : 138, 1977